Complexity against current cancer research: Are we on the wrong track?
Y Kasikci, H Gronemeyer - International journal of cancer, 2022 - Wiley Online Library
Cancer genetics has led to major discoveries, including protooncogene and tumor‐
suppressor concepts, and cancer genomics generated concepts like driver and passenger …
suppressor concepts, and cancer genomics generated concepts like driver and passenger …
Lymphatic dissemination in prostate cancer: features of the transcriptomic profile and prognostic models
EA Pudova, AA Kobelyatskaya, IV Katunina… - International Journal of …, 2023 - mdpi.com
Radical prostatectomy is the gold standard treatment for prostate cancer (PCa); however, it
does not always completely cure PCa, and patients often experience a recurrence of the …
does not always completely cure PCa, and patients often experience a recurrence of the …
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer
M Nouri, A Varkaris, M Ridinger, SL Dalrymple… - Molecular Cancer …, 2024 - AACR
Abstract Polo-like kinase 1 (PLK1) inhibitors have had limited antitumor efficacy as single
agents, and a focus of current efforts is on combination therapies. We initially confirmed that …
agents, and a focus of current efforts is on combination therapies. We initially confirmed that …
SPLICE-q: a Python tool for genome-wide quantification of splicing efficiency
VR de Melo Costa, J Pfeuffer, A Louloupi, UAV Ørom… - BMC …, 2021 - Springer
Background Introns are generally removed from primary transcripts to form mature RNA
molecules in a post-transcriptional process called splicing. An efficient splicing of primary …
molecules in a post-transcriptional process called splicing. An efficient splicing of primary …
Canonical AREs are tumor suppressive regulatory elements in the prostate
The androgen receptor (AR) is the central determinant of prostate tissue identity and
differentiation, controlling normal, growth-suppressive prostate-specific gene expression. It …
differentiation, controlling normal, growth-suppressive prostate-specific gene expression. It …
[HTML][HTML] Transcriptome Data Reveal Geographic Heterogeneity in Gene Expression in Patients with Prostate Cancer
Y Zheng, Y Wang, H He, Z Zou, H Lu, J Li… - … of Biochemistry & …, 2023 - ncbi.nlm.nih.gov
Background: The incidence of prostate cancer (PC) exhibits geographical heterogeneity.
However, the metabolic mechanisms underlying this geographic heterogeneity remain …
However, the metabolic mechanisms underlying this geographic heterogeneity remain …
Investigating the Role of SPP1 (Osteopontin) in the Progression of Breast and other Cancers
G Kundu, S Elangovan - 2024 - preprints.org
Background/Objectives: Cancer is caused by disruptions in the homeostatic state of normal
cells, which results in dysregulation of the cell cycle, and uncontrolled growth and …
cells, which results in dysregulation of the cell cycle, and uncontrolled growth and …
Patient-derived prostate cancer organoids require α6-integrins for self-renewal and recapitulate genetic heterogeneity and histopathology of the original tumors
R Devarajan, A Hawash, S Koivusalo, A Tervasmäki… - 2023 - researchsquare.com
Background: Modeling the pathophysiology of prostate cancer (PCa) remains a challenge
and primary tissue-derived organoid cultures have emerged as promising models …
and primary tissue-derived organoid cultures have emerged as promising models …
[图书][B] Genome-wide Determination Of Splicing Efficiency And Dynamics From RNA-Seq Data
VR de Melo Costa - 2020 - search.proquest.com
Eukaryotic genes are mostly composed of a series of exons intercalated by sequences with
no coding potential called introns. These sequences are generally removed from primary …
no coding potential called introns. These sequences are generally removed from primary …